Over the years, several anti-obesity drugs have been used to support nutritional therapy in patients with PWS [31, 49]
This group also had a higher prevalence of comorbidities, including hypertension, dyslipidemia, heart failure, diabetic complications, overweight and obesity, chronic lower respiratory diseases, cystic kidney disease and neoplasms
Treatment with the glucagon receptor antagonist LY2409021 increases ambulatory blood pressure in patients with type 2 diabetes
Importantly, variability is large across people because microbiome composition differs
Hood, Meininger, Ziche, Granger, "VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells," Am